Teladoc Cuts Revenue Forecast on Weaker BetterHelp Demand, Shares Plunge

Teladoc Health has revised its 2024 revenue forecast downward due to shifting demand for its online therapy platform BetterHelp, leading to a sharp decline in its stock price. The company cited weaker-than-expected customer demand, particularly in the BetterHelp segment, which negatively impacted overall revenue expectations. According to the new guidance, Teladoc's total revenue for 2024 will fall below the previously projected range. This revision reflects the challenges Teladoc faces as demand for online health services normalizes in the post-pandemic period. BetterHelp experienced significant growth during the pandemic but has recently seen a decline in demand. Analysts suggest that this demand shift could pressure Teladoc's long-term growth strategy. While the company is implementing cost control and operational efficiency measures to navigate this period, the lowered revenue forecast has shaken investor confidence. Teladoc shares lost over 20% in trading following the announcement. The company has outlined plans to restructure BetterHelp and focus on new growth areas, though the market remains cautious about the short-term impact of these steps. This is not investment advice.